SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    T. Menge, B.C. Kieseier, C. Warnke, O. Aktas, H.-P. Hartung, Alemtuzumab: eine weitere Chance zur Therapie der Multiplen Sklerose, Der Nervenarzt, 2012, 83, 4, 487

    CrossRef

  2. 2
    Roberto Stasi, Adrian C. Newland, ITP: a historical perspective, British Journal of Haematology, 2011, 153, 4
  3. 3
    D. Gomez-Almaguer, M. Solano-Genesta, L. Tarin-Arzaga, J. L. Herrera-Garza, O. G. Cantu-Rodriguez, C. H. Gutierrez-Aguirre, J. C. Jaime-Perez, Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias, Blood, 2010, 116, 23, 4783

    CrossRef

  4. 4
    Joanne L. Jones, Alasdair J. Coles, New treatment strategies in multiple sclerosis, Experimental Neurology, 2010, 225, 1, 34

    CrossRef

  5. 5
    C. Warnke, B.C. Kieseier, U. Zettl, H-P. Hartung, Alemtuzumab als neue Therapieoption der Multiplen Sklerose, Der Nervenarzt, 2009, 80, 4, 468

    CrossRef

  6. 6
    Tadeusz Robak, Alemtuzumab for B-cell chronic lymphocytic leukemia, Expert Review of Anticancer Therapy, 2008, 8, 7, 1033

    CrossRef

  7. 7
    Xiaofang Li, Ming Hou, Emerging drugs for idiopathic thrombocytopenic purpura in adults, Expert Opinion on Emerging Drugs, 2008, 13, 2, 237

    CrossRef

  8. 8
    B. Godeau, P. Bierling, Purpura thrombopénique auto-immun, EMC - Hématologie, 2008, 3, 2, 1

    CrossRef

  9. 9
    Klaus Lechner, Ansgar Weltermann, Ingrid Pabinger, Autoimmunthrombozytopenie (AITP) des Erwachsenen: Klinik, Diagnose und Therapie, Wiener klinische Wochenschrift, 2006, 118, 9-10, 255

    CrossRef

  10. 10
    A. J. Coles, A. Cox, E. Page, J. Jones, S. A. Trip, J. Deans, S. Seaman, D. H. Miller, G. Hale, H. Waldmann, D. A. Compston, The window of therapeutic opportunity in multiple sclerosis, Journal of Neurology, 2006, 253, 1, 98

    CrossRef

  11. 11
    James Bussel, Treatment of Immune Thrombocytopenic Purpura in Adults, Seminars in Hematology, 2006, 43, S3

    CrossRef

  12. 12
    B. H. CHONG, S.-J. HO, Autoimmune thrombocytopenia, Journal of Thrombosis and Haemostasis, 2005, 3, 8
  13. 13
    Iman Jilani, Michael Keating, Francis J. Giles, Susan O’Brien, Hagop M. Kantarjian, Maher Albitar, Alemtuzumab: validation of a sensitive and simple enzyme-linked immunosorbent assay, Leukemia Research, 2004, 28, 12, 1255

    CrossRef

  14. 14
    Alasdair Coles, Jackie Deans, Alastair Compston, Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench, Clinical Neurology and Neurosurgery, 2004, 106, 3, 270

    CrossRef

  15. 15
    Roberto Stasi, Drew Provan, Management of Immune Thrombocytopenic Purpura in Adults, Mayo Clinic Proceedings, 2004, 79, 4, 504

    CrossRef

  16. 16
    Tadeusz Robak, Monoclonal antibodies in the treatment of autoimmune cytopenias, European Journal of Haematology, 2004, 72, 2
  17. 17
    E. Ammatuna, C. Marino, M. E. Mitra, G. Calvaruso, E. Iannitto, Successful treatment of steroid resistant autoimmune thrombocytopenia associated with chronic lymphocytic leukemia with alemtuzumab, European Journal of Haematology, 2004, 73, 3
  18. 18
    Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy, British Journal of Haematology, 2003, 120, 4
  19. 19
    A. Khorana, P. Bunn, P. McLaughlin, J. Vose, C. Stewart, M. S. Czuczman, A Phase II Multicenter Study of CAMPATH-1H Antibody in Previously Treated Patients with Nonbulky Non-Hodgkin's Lymphoma, Leukemia & Lymphoma, 2001, 41, 1-2, 77

    CrossRef

  20. 20
    Laura L. Worth, Sima S. Jeha, Eugenie S. Kleinerman, BIOLOGIC RESPONSE MODIFIERS IN PEDRIATIC CANCER, Hematology/Oncology Clinics of North America, 2001, 15, 4, 723

    CrossRef

  21. 21
    Klaus Lechner, MANAGEMENTOF ADULT IMMUNE THROMBOCYTOPENIA, Reviews in Clinical and Experimental Hematology, 2001, 5, 3
  22. 22
    F. Willis, J. C. W. Marsh, D. H. Bevan, S. B. Killick, G. Lucas, R. Griffiths, W. Ouwehand, G. Hale, H. Waldmann, E. C. Gordon-smith, The effect of treatment with Campath-1H in patients with autoimmune cytopenias, British Journal of Haematology, 2001, 114, 4
  23. 23
    Wendell F. Rosse, Paroxysmal Nocturnal Hemoglobinuria as a Molecular Disease, Medicine, 1997, 76, 2, 63

    CrossRef

  24. 24
    MARJORIE A SMITH, MARK EASTON, PETER EVERETT, GARNET LEWIS, MICHAEL PAYNE, VALENTINA RIVEROS-MORENO, GEOFFREY ALLEN, Specific cleavage of immunoglobulin G by copper ions, International Journal of Peptide and Protein Research, 1996, 48, 1
  25. 25
    B Godeau, P Bierling, Traitement du purpura thrombopénique auto-immun de l'adulte, La Revue de Médecine Interne, 1996, 17, 8, 661

    CrossRef

  26. 26
    GEOFF HALE, HERMAN WALDMANN, CAMPATH-1 Monoclonal Antibodies in Bone Marrow Transplantation, Journal of Hematotherapy, 1994, 3, 1, 15

    CrossRef